Navigation Links
Aspergillus Precipitin

ProductsAspergillus Precipitin
Company ARUP Laboratories
Item Aspergillus Precipitin
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Bio-Rad Platelia Aspergillus EIA
2. Aspergillus Antibodies by CF & ID
3. Aspergillus Antibody by ID
4. Aspergillus Antibody by CF
5. Aspergillus Galactomannan Antigen by EIA
6. Aspergillus Niger IgE
7. PlateliaAspergillus
8. Allergen, Fungi & Molds, Aspergillus fumigatus
9. Allergen, Fungi & Molds, Aspergillus fumigatus IgG
10. Blastomyces Precipitin
11. Histoplasma Precipitin by ID
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:New approach to sickle-cell disease shows promise in mice 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 1Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 2Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 3Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 1Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 1Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 9